Results

Total Results: 3,901 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - growth hormone (rhGH), we needed to devise key questions that, when subsequently answered in the next phase … This completes the topic refinement project and sets the stage for the next phase, in which the key questions … Studies are evaluated in this phase to review methods and demographics, not results.
  2. digital.ahrq.gov/sites/default/files/docs/citation/r18hs018865-wood-final-report-2015.pdf
    January 01, 2015 - The implementation of the improvements in the KeyHIE, which was the second phase of the KeyHIE project
  3. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/864867/psn-pdf
    April 10, 2024 - treatment using a mobile stroke unit compared with standard management: The BEST-MSU Study run-in phase
  4. www.ahrq.gov/sites/default/files/2025-05/wears2-report.pdf
    January 01, 2025 - at the National Library of Medicine and has successfully obtained funding to support the pilot phase
  5. psnet.ahrq.gov/web-mm/hindsight-2020-thrombolytics-alcohol-intoxication
    December 18, 2024 - stroke treatment using a mobile stroke unit compared with standard management: The BEST-MSU Study run-in phase
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
    July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 2 2-1 Chapter 2 Developing the Topic and Structuring Systematic Reviews of Medical Tests: Utility of PICOTS, Analytic Frameworks, Decision Trees, and Other Frameworks David Samson, M.S., Blue Cross and Blue Shield Association Karen M. Schoelles M.D., S.…
  7. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-surgery/105-what-are-the-4-es-notes.docx
    April 01, 2025 - In the execute phase, it is common to discover shortcomings of the plan, so it is important to get feedback … In the Execution phase, the guiding principle is to make it easy for people to make the right decision
  8. digital.ahrq.gov/ahrq-funded-projects/using-health-information-technology-improve-ambulatory-chronic-disease-care
    January 01, 2023 - Using Health Information Technology to Improve Ambulatory Chronic Disease Care Project Final Report ( PDF , 769.48 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily rep…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
    April 01, 2011 - Takeda has completed a phase 1, randomized, open-label, 2 period, crossover study to evaluate the effect … release (MR) - The objective of the study was to assess the safety of dexlansoprazole MR from the phase … Pediatric patients - Dexlansoprazole is not FDA approved for use in patients less than 18 years of age.1A phase … dexlansoprazole in adolescents 12-17 years of age with symptomatic GERD has been completed.8 A second phase
  10. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
    March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion
  12. effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase … III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the six topics for which (1) preliminary phase III data were available … Currently interventions such as this humanoid robotic doll are in an early phase of development and
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - In the title/abstract screening phase, all references will undergo dual review by a senior and a junior … will be pooled by using the methods of Curtin et al.,39, 40 or if not possible, using only the first phase … While complete specification of data to be extracted will be developed during the abstraction phase, … Phase III evaluation of fluoxetine for treatment of hot flashes.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
    June 20, 2024 - specified, is unclear) Interventions ALL Key Questions • FDA approved devices or materials (or in Phase … Evoked Potentials (SSEP), ALL Key Questions • Devices or materials that are not FDA approved or in Phase … Direct Stimulation Comparators ALL Key Questions • FDA approved devices or materials (or in Phase … Conservative care, non-operative care, usual care • Devices or materials that are not FDA approved or in Phase
  15. www.ahrq.gov/sites/default/files/2024-01/schnipper-report.pdf
    January 01, 2024 - was the long delay between sites signing up for the study (i.e., during the grant application 18 phase
  16. psnet.ahrq.gov/primer/coronavirus-disease-2019-covid-19-and-safety-older-adults
    April 10, 2024 - reopen including: Criteria, based on an individual state’s level of community transmission, to determine phase … Reopening nursing homes–phase 1–how does it begin? CMS Compliance Group, Inc . May 21, 2020.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections
  19. hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.jsp
    July 01, 2016 - DOH feels that this project has set a good foundation for either taking this activity into a pilot phase … Given the current budget crisis, AHRQ may be able to kick start the next development phase by providing
  20. Wafinalreport042309 (pdf file)

    hcup-us.ahrq.gov/datainnovations/clinicaldata/WAFinalReport042309.pdf
    April 23, 2009 - DOH feels that this project has set a good foundation for either taking this activity into a pilot phase … Given the current budget crisis, AHRQ may be able to kick start the next development phase by providing